M Laé1, A Lebel2, F Hamel-Viard1, B Asselain3, M Trassard1, X Sastre1, Y M Kirova4. 1. Département de biologie des tumeurs, 26, rue d'Ulm, 75005 Paris, France. 2. Département d'oncologie radiothérapie, 26, rue d'Ulm, 75005 Paris, France. 3. Département de biostatistiques, institut Curie, 26, rue d'Ulm, 75005 Paris, France. 4. Département d'oncologie radiothérapie, 26, rue d'Ulm, 75005 Paris, France. Electronic address: youlia.kirova@curie.fr.
Abstract
PURPOSE: Breast angiosarcomas are rare vascular malignancies that arise secondary to irradiation or de novo as primary tumours. The aim of this study is to know whether c-myc amplification can reliably discriminate these two entities. MATERIEL AND METHODS: Forty-seven patients treated for breast angiosarcomas were studied. Thirty-two patients were diagnosed with postradiation angiosarcomas after breast cancer treatment and 15 patients with primary angiosarcomas. Interphase fluorescence in situ hybridization (FISH) was performed by hybridization of probes covering C-MYC (chromosome 8q24.21) and CEP8 on tissue sections. RESULTS: Amplification (5- to 20-fold) of the c-myc oncogene was found in all breast radiation-induced angiosarcomas (32 tumours) but in none of the 15 primary angiosarcomas except one (7%). CONCLUSION: This study reinforces that there are true pathogenetic differences between the two types of breast angiosarcomas which are morphologically indistinguishable. These data point the pathways preferentially involved in the pathogenesis of post radiation angiosarcomas of the breast and may provide the basis for an additional targeted therapy.
PURPOSE: Breast angiosarcomas are rare vascular malignancies that arise secondary to irradiation or de novo as primary tumours. The aim of this study is to know whether c-myc amplification can reliably discriminate these two entities. MATERIEL AND METHODS: Forty-seven patients treated for breast angiosarcomas were studied. Thirty-two patients were diagnosed with postradiation angiosarcomas after breast cancer treatment and 15 patients with primary angiosarcomas. Interphase fluorescence in situ hybridization (FISH) was performed by hybridization of probes covering C-MYC (chromosome 8q24.21) and CEP8 on tissue sections. RESULTS: Amplification (5- to 20-fold) of the c-myc oncogene was found in all breast radiation-induced angiosarcomas (32 tumours) but in none of the 15 primary angiosarcomas except one (7%). CONCLUSION: This study reinforces that there are true pathogenetic differences between the two types of breast angiosarcomas which are morphologically indistinguishable. These data point the pathways preferentially involved in the pathogenesis of post radiation angiosarcomas of the breast and may provide the basis for an additional targeted therapy.
Authors: Isidro Machado; Francisco Giner; Javier Lavernia; Julia Cruz; Víctor Traves; Celia Requena; Beatriz Llombart; José Antonio López-Guerrero; Antonio Llombart-Bosch Journal: Histol Histopathol Date: 2020-09-04 Impact factor: 2.303
Authors: Lucas Aguiar Alencar de Oliveira; Antonio Fortes de Pádua Filho; Maria Adélia Medeiros E Melo; Elisa Rosa de Carvalho Gonçalves Nunes Galvão; Mharcus Carneiro Vieira; Jerúsia Oliveira Ibiapina; Danilo Rafael da Silva Fontinele; Sabas Carlos Vieira Journal: Einstein (Sao Paulo) Date: 2020-12-07
Authors: Maria Gabriela Kuba; Bin Xu; Sandra P D'Angelo; Evan Rosenbaum; George Plitas; Dara S Ross; Edi Brogi; Cristina R Antonescu Journal: Histopathology Date: 2021-09-05 Impact factor: 5.087
Authors: Askin Dogan; Peter Kern; Beate Schultheis; Günther Häusler; Günther A Rezniczek; Clemens B Tempfer Journal: BMC Cancer Date: 2018-04-24 Impact factor: 4.430